These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30786948)

  • 1. ESBL-colonization at ICU admission: impact on subsequent infection, carbapenem-consumption, and outcome.
    Emmanuel Martinez A; Widmer A; Frei R; Pargger H; Tuchscherer D; Marsch S; Egli A; Tschudin-Sutter S
    Infect Control Hosp Epidemiol; 2019 Apr; 40(4):408-413. PubMed ID: 30786948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colonization and infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in ICU patients: what impact on outcomes and carbapenem exposure?
    Barbier F; Pommier C; Essaied W; Garrouste-Orgeas M; Schwebel C; Ruckly S; Dumenil AS; Lemiale V; Mourvillier B; Clec'h C; Darmon M; Laurent V; Marcotte G; Lucet JC; Souweine B; Zahar JR; Timsit JF;
    J Antimicrob Chemother; 2016 Apr; 71(4):1088-97. PubMed ID: 26755492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cessation of screening for intestinal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in a low-endemicity intensive care unit with universal contact precautions.
    Jalalzaï W; Boutrot M; Guinard J; Guigon A; Bret L; Poisson DM; Boulain T; Barbier F
    Clin Microbiol Infect; 2018 Apr; 24(4):429.e7-429.e12. PubMed ID: 28962997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact and risk factors for colonization with extended-spectrum β-lactamase-producing bacteria in the intensive care unit.
    Razazi K; Derde LP; Verachten M; Legrand P; Lesprit P; Brun-Buisson C
    Intensive Care Med; 2012 Nov; 38(11):1769-78. PubMed ID: 22893223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantifying risk of disease due to extended-spectrum β-lactamase producing Enterobacteriaceae in patients who are colonized at ICU admission.
    Razazi K; Rosman J; Phan AD; Carteaux G; Decousser JW; Woerther PL; de Prost N; Brun-Buisson C; Mekontso Dessap A
    J Infect; 2020 May; 80(5):504-510. PubMed ID: 32142931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for colonization with extended-spectrum beta-lactamase-producing enterobacteriaceae on admission to rehabilitation centres.
    Bilavsky E; Temkin E; Lerman Y; Rabinovich A; Salomon J; Lawrence C; Rossini A; Salvia A; Samso JV; Fierro J; Paul M; Hart J; Gniadkowski M; Hochman M; Kazma M; Klein A; Adler A; Schwaber MJ; Carmeli Y;
    Clin Microbiol Infect; 2014 Nov; 20(11):O804-10. PubMed ID: 24674024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective evaluation of colonization with extended-spectrum beta-lactamase (ESBL)-producing enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing enterobacteriaceae among patients during hospitalization.
    Friedmann R; Raveh D; Zartzer E; Rudensky B; Broide E; Attias D; Yinnon AM
    Infect Control Hosp Epidemiol; 2009 Jun; 30(6):534-42. PubMed ID: 19419270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How Should We Treat Hospital-Acquired and Ventilator-Associated Pneumonia Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae?
    Timsit JF; Pilmis B; Zahar JR
    Semin Respir Crit Care Med; 2017 Jun; 38(3):287-300. PubMed ID: 28578553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors for Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Carriage in Patients Admitted to Intensive Care Unit in a Tertiary Care Hospital in Thailand.
    Kiddee A; Assawatheptawee K; Na-Udom A; Boonsawang P; Treebupachatsakul P; Walsh TR; Niumsup PR
    Microb Drug Resist; 2019 Oct; 25(8):1182-1190. PubMed ID: 31140920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ICU Acquisition Rate, Risk Factors, and Clinical Significance of Digestive Tract Colonization With Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae: A Systematic Review and Meta-Analysis.
    Detsis M; Karanika S; Mylonakis E
    Crit Care Med; 2017 Apr; 45(4):705-714. PubMed ID: 28157141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carriage of ESBL-producing Enterobacteriaceae in French hospitals: the PORTABLSE study.
    Pilmis B; Cattoir V; Lecointe D; Limelette A; Grall I; Mizrahi A; Marcade G; Poilane I; Guillard T; Bourgeois Nicolaos N; Zahar JR; Le Monnier A
    J Hosp Infect; 2018 Mar; 98(3):247-252. PubMed ID: 29222035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended spectrum beta-lactamase producing
    Prevel R; Boyer A; M'Zali F; Cockenpot T; Lasheras A; Dubois V; Gruson D
    Antimicrob Resist Infect Control; 2019; 8():112. PubMed ID: 31333839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors for extended-spectrum beta-lactamase producing Enterobacteriaceae causing infection among intensive care unit patients with prior colonization.
    Vodovar D; Marcadé G; Rousseau H; Raskine L; Vicaut E; Deye N; Baud FJ; Mégarbane B
    Infection; 2014 Aug; 42(4):743-8. PubMed ID: 24728816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is systematic fecal carriage screening of extended-spectrum beta-lactamase-producing Enterobacteriaceae still useful in intensive care unit: a systematic review.
    Prevel R; Boyer A; M'Zali F; Lasheras A; Zahar JR; Rogues AM; Gruson D
    Crit Care; 2019 May; 23(1):170. PubMed ID: 31088542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between colonization with carbapenemase-producing enterobacteriaceae and overall ICU mortality: an observational cohort study.
    Dautzenberg MJ; Wekesa AN; Gniadkowski M; Antoniadou A; Giamarellou H; Petrikkos GL; Skiada A; Brun-Buisson C; Bonten MJ; Derde LP;
    Crit Care Med; 2015 Jun; 43(6):1170-7. PubMed ID: 25882764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of bacterial colonization at intensive care unit admission with emphasis on extended-spectrum beta-lactamase- and metallo-beta-lactamase-producing Gram-negative bacteria--an Indian experience.
    Azim A; Dwivedi M; Rao PB; Baronia AK; Singh RK; Prasad KN; Poddar B; Mishra A; Gurjar M; Dhole TN
    J Med Microbiol; 2010 Aug; 59(Pt 8):955-960. PubMed ID: 20413621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of colonization pressure on acquisition of extended-spectrum β-lactamase-producing Enterobacterales and meticillin-resistant Staphylococcus aureus in two intensive care units: a 19-year retrospective surveillance.
    Jolivet S; Lolom I; Bailly S; Bouadma L; Lortat-Jacob B; Montravers P; Armand-Lefevre L; Timsit JF; Lucet JC
    J Hosp Infect; 2020 May; 105(1):10-16. PubMed ID: 32092367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colonization by fecal extended-spectrum β-lactamase-producing Enterobacteriaceae and surgical site infections in patients with cancer undergoing gastrointestinal and gynecologic surgery.
    Golzarri MF; Silva-Sánchez J; Cornejo-Juárez P; Barrios-Camacho H; Chora-Hernández LD; Velázquez-Acosta C; Vilar-Compte D
    Am J Infect Control; 2019 Aug; 47(8):916-921. PubMed ID: 30850249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection-related ventilator-associated complications in ICU patients colonised with extended-spectrum β-lactamase-producing Enterobacteriaceae.
    Barbier F; Bailly S; Schwebel C; Papazian L; Azoulay É; Kallel H; Siami S; Argaud L; Marcotte G; Misset B; Reignier J; Darmon M; Zahar JR; Goldgran-Toledano D; de Montmollin É; Souweine B; Mourvillier B; Timsit JF;
    Intensive Care Med; 2018 May; 44(5):616-626. PubMed ID: 29663045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for colonization with multiple species of extended-spectrum beta-lactamase producing Enterobacterales: a case-case-control study.
    Vock I; Aguilar-Bultet L; Egli A; Tamma PD; Tschudin-Sutter S
    Antimicrob Resist Infect Control; 2021 Oct; 10(1):153. PubMed ID: 34689820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.